Scientists at Boston University discovered Resolvins, a new family of biologically active products of omega-3 fatty acids with therapeutic potential. These compounds have been shown to resolve periodontal inflammation and regenerate tissues in experimental gum disease models.
A study of 36,903 men found significant associations between obesity measures and periodontal disease. Obesity was associated with a 25% and 29% increased risk of periodontal disease compared to normal weight, with waist circumference and waist-to-hip ratio also linked to an increased risk.
A new study led by NYU dental researcher Dr. Ananda P. Dasanayake found that pregnant women with periodontal disease are more likely to develop gestational diabetes. The study, conducted in Sri Lanka, eliminated smoking and alcohol use among participants to isolate the impact of gum disease on glucose levels.
Researchers have developed a method to generate complex, multilayer oral tissues using human embryonic stem cells. The tissues mimic normal oral cavity tissues and show promise for treating oral diseases through transplantation.
Studies link periodontal disease to infant prematurity, diabetes, and stroke. Treating pregnant women with scaling and root planing can save nearly $14 million worldwide.